Literature DB >> 7494004

Interaction of streptokinase and plasminogen. Studied with truncated streptokinase peptides.

K C Young1, G Y Shi, Y F Chang, B I Chang, L C Chang, M D Lai, W J Chuang, H L Wu.   

Abstract

The interaction of streptokinase (SK) with human plasminogen (HPlg) was investigated using truncated SK peptides prepared by gene cloning techniques. SK(16-414) and SK(16-378) could activate HPlg as efficiently as the authentic SK. SK(60-414), which had been preincubated with SK(1-59), could also activate HPlg. SK(91-414), SK(127-414), and SK(158-414), at a concentration of one-tenth of HPlg, all failed to activate HPlg. However, the truncated SK peptides in complexes with equimolar HPlg could form amidolytically active virgin enzymes that slowly converted to human plasmin (HPlm) after a lag period of 15 min. SK(16-316) could not activate HPlg. No virgin enzyme was detected when SK(16-316) was incubated with equimolar HPlg, but the HPlg in the complex was modified to HPlm after reaction for 20 min. SK(220-414) and SK(16-251) had no ability to transform HPlg to virgin enzyme or to HPlm in equimolar complex with HPlg, although they could bind to HPlg. The functions of five regions in the SK molecule (a, Ile1-Lys59; b, Ser60-Asn90; c, Val158-Arg219; d, Tyr252-Ala316; e, Ser317-Ala378) in interaction with HPlg are deduced. Region a is important in stabilizing the conformation of the SK molecule, and region b is essential for HPlg activation. Region c is required for induction of the conformational changes of HPlg to virgin enzyme. Regions c and d are required for the conversion of HPlg to HPlm in the HPlg.SK equimolar complex. Coordination of regions c, d, and e of SK is essential for a virgin enzyme formation, and coordination of regions b, c, d and e is required for an effective SK-type HPlg activator.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494004     DOI: 10.1074/jbc.270.49.29601

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  A catalytic switch and the conversion of streptokinase to a fibrin-targeted plasminogen activator.

Authors:  G L Reed; A K Houng; L Liu; B Parhami-Seren; L H Matsueda; S Wang; L Hedstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Expression and characterization of the intact N-terminal domain of streptokinase.

Authors:  A I Azuaga; N D Woodruff; F Conejero-Lara; V F Cox; R A Smith; C M Dobson
Journal:  Protein Sci       Date:  1999-02       Impact factor: 6.725

3.  Identification through combinatorial random and rational mutagenesis of a substrate-interacting exosite in the gamma domain of streptokinase.

Authors:  Suman Yadav; Rachna Aneja; Prakash Kumar; Manish Datt; Sonali Sinha; Girish Sahni
Journal:  J Biol Chem       Date:  2010-12-17       Impact factor: 5.157

Review 4.  Streptokinase--the drug of choice for thrombolytic therapy.

Authors:  Adinarayana Kunamneni; Thaer Taleb Abed Abdelghani; Poluri Ellaiah
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

5.  Role of the amino-terminal region of streptokinase in the generation of a fully functional plasminogen activator complex probed with synthetic peptides.

Authors:  D Nihalani; R Kumar; K Rajagopal; G Sahni
Journal:  Protein Sci       Date:  1998-03       Impact factor: 6.725

6.  Antithrombogenic properties of bioconjugate streptokinase-polyglycerol dendrimers.

Authors:  Edson Giuliani Ramos Fernandes; Alvaro Antonio Alencar de Queiroz; Gustavo A Abraham; Julio San Román
Journal:  J Mater Sci Mater Med       Date:  2006-02       Impact factor: 3.896

7.  Thermal stability of the three domains of streptokinase studied by circular dichroism and nuclear magnetic resonance.

Authors:  F Conejero-Lara; J Parrado; A I Azuaga; R A Smith; C P Ponting; C M Dobson
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

8.  Engineering of plasmin-resistant forms of streptokinase and their production in Bacillus subtilis: streptokinase with longer functional half-life.

Authors:  X C Wu; R Ye; Y Duan; S L Wong
Journal:  Appl Environ Microbiol       Date:  1998-03       Impact factor: 4.792

9.  Purification and cloning of a streptokinase from Streptococcus uberis.

Authors:  L B Johnsen; K Poulsen; M Kilian; T E Petersen
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

10.  Analysis of the interactions between streptokinase domains and human plasminogen.

Authors:  F Conejero-Lara; J Parrado; A I Azuaga; C M Dobson; C P Ponting
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.